René Rebollo has more than seven years of experience in pharmaceutical formulation and technology transfer, he has been part of Novo Nordisk A/S since 2021. He completed a BSc in biopharmaceutical chemistry in the Autonomous University of the State of Mexico, with a speciality in industrial pharmacy; and an Erasmus Mundus Joined Master’s degree in Nanomedicine for drug delivery by the University of Paris Cité, University of Angers, University of Patras and University of Pavia. He’s currently enrolled as an industrial PhD with Novo Nordisk and the Technical University of Denmark.